Both compounds target body-weight reduction in obesity research, but they get there through completely different receptors. Understanding the mechanism gap is the difference between picking the right tool for a research question and wasting a 24-week protocol.
Retatrutide (LY3437943, Eli Lilly) is a synthetic triple agonist developed by Coskun and colleagues that activates the GLP-1, GIP, and glucagon receptors simultaneously (Coskun 2022). Cagrilintide (AM833, Novo Nordisk) is a long-acting analogue of human amylin, a 37-amino-acid hormone co-secreted with insulin from pancreatic beta cells. The amylin receptor is a calcitonin-receptor/RAMP heterodimer expressed densely in the area postrema — the brainstem nausea/satiety hub.
This receptor-level divergence drives every downstream difference: dose curves, side-effect profiles, combination logic, and the kind of research question each compound answers best.
| Property | Retatrutide | Cagrilintide |
|---|---|---|
| Class | Triple incretin agonist | Amylin analogue |
| Receptors | GLP-1R + GIPR + GCGR | Amylin (CTR + RAMP) |
| Primary CNS target | Arcuate nucleus, hypothalamus | Area postrema, NTS |
| Peripheral effect | Insulin secretion + energy expenditure | Slowed gastric emptying, glucagon suppression |
| Half-life | ~6 days | ~7-8 days (weekly SC) |
| Studied weight loss (mono) | ~24.2% at 48 wk (12 mg) | ~10.8% at 26 wk (2.4 mg) |
| Key Phase 2 trial | Jastreboff 2023 NEJM | Lau 2021 Lancet |
Retatrutide's glucagon arm is the unusual feature — most weight-loss research drugs avoid glucagon because of glycemic concerns, but Lilly's structural approach lets the GLP-1 component buffer glucose while glucagon drives lipolysis and energy expenditure. That third receptor is why the dose curve in Jastreboff 2023 keeps descending past 8 mg when GLP-1 monotherapies have already plateaued.
Cagrilintide takes a complementary route: it doesn't push energy expenditure, it crushes hunger signalling through a different brain region than GLP-1. That mechanistic separation is exactly why the CagriSema combination was designed.
CagriSema is the fixed-ratio combination of cagrilintide 2.4 mg + semaglutide 2.4 mg, weekly SC. The Phase 2 trial (Enebo 2021, Lancet) in type 2 diabetes showed superiority over either component alone. The pivotal REDEFINE-1 Phase 3 trial (Garvey 2025) extended this to non-diabetic obesity:
| Arm | Weight loss at 68 wk | Notes |
|---|---|---|
| Placebo | ~2.3% | Lifestyle only |
| Cagrilintide 2.4 mg mono | ~11.5% | Amylin alone |
| Semaglutide 2.4 mg mono | ~16.1% | GLP-1 alone |
| CagriSema 2.4/2.4 mg | ~22.7% | Combination |
The combination effect is roughly additive rather than synergistic, but ~22.7% closes most of the gap with retatrutide 12 mg monotherapy at 24.2%. The trade-off is two molecules' worth of side-effect surface area and a more complex injection schedule. For a UAE researcher choosing between a single-molecule triple-agonist or a dual-injection combo, retatrutide's logistical simplicity is a real advantage.
For tolerability management in either compound, see our GLP-1 and incretin nausea mitigation protocols — most of the same tactics (evening dosing, low-fat 48h post-injection, ginger, electrolyte loading) work for both classes.
For most UAE labs running general obesity, metabolic syndrome, or MASH research, retatrutide is the default workhorse. Cagrilintide earns its place in studies designed around amylin biology specifically or combination pharmacology.
REVIVE Peptides operates from Dubai with a temperature-controlled warehouse and a dispatch desk covering all seven emirates. Cagrilintide is not currently in our UAE inventory; retatrutide is the in-stock triple-agonist alternative.
| Emirate | Delivery window | Cold-chain | Cut-off |
|---|---|---|---|
| Dubai | Same-day | Ice-pack courier | Order by 2pm |
| Abu Dhabi | Next-day (24h) | Insulated overnight | Order by 5pm |
| Sharjah | Same/next-day | Ice-pack courier | Order by 3pm |
| Ajman | Next-day (24h) | Insulated overnight | Order by 5pm |
| Ras Al Khaimah | 24-48h | Insulated overnight | Order by 4pm |
| Fujairah / UAQ | 48h | Insulated overnight | Order by 4pm |
Cold-chain logistics. Lyophilised retatrutide is stable at 2-8 degC; in UAE summer ambient (45 degC+) the dispatch protocol uses pre-conditioned gel packs in expanded-polystyrene insulated boxes rated for 24-36 hours of thermal protection. Sealed lyo vials tolerate brief room-temperature exposure but cold-chain is non-negotiable for inter-emirate dispatch in July-September.
REVIVE Dubai stock. Current inventory: Retatrutide 5 mg and 10 mg, Tesamorelin 5/10 mg, GHK-Cu 50/100 mg, BPC-157 5 mg, TB-500 5 mg, MOTS-c 10 mg, Semax 10 mg, NAD+ 100 mg, and Bacteriostatic Water 3 mL. Each retatrutide batch ships with a third-party HPLC purity certificate.
Ordering process. Place the order via the retatrutide product page, complete checkout, and receive a dispatch confirmation with courier tracking. Same-day Dubai orders are typically delivered between 4pm and 9pm. For bulk orders or research-grade quantities, the UAE peptide catalogue page lists volume pricing.
Per Drucker 2024 and Müller 2019 review work, cost-per-percent-weight-loss is a fair way to compare incretin and amylin research compounds across a 24-week protocol. Retatrutide's wider dose range (0.5-12 mg) lets a single 10 mg vial cover roughly 20 weeks at a 0.5 mg starting dose, or 2.5 weeks at 4 mg. Cagrilintide protocols typically run 0.3-2.4 mg, so vial economics are similar at maintenance doses. For combination protocols (CagriSema model) you double the spend.
For step-by-step reconstitution see our retatrutide reconstitution math guide; for the 24-week dose escalation see the retatrutide titration schedule UAE.
If you are running a single-molecule obesity or MASH study and want maximum effect-size headroom plus simple weekly dosing, retatrutide is the cleaner choice — and it is the one REVIVE actually stocks in Dubai for 24h delivery. If your protocol specifically dissects amylin biology or replicates the CagriSema combination, cagrilintide has its place, but you will source it elsewhere and accept a longer lead time.
For most labs we work with across Dubai, Abu Dhabi, and Sharjah, the practical answer is to buy retatrutide UAE 24h delivery from REVIVE and reserve cagrilintide procurement for combination-specific projects.